Clinical studies showed that patients receiving chemotherapy have increased NFκB activity and cytokine expression, such as CXCL8, and a high level of CXCL8 compromises the docetaxel-mediated apoptosis of tumor cells14,15. The gene discussed is CXCL8; the disease is neoplasm.